BSE: STARIMAGIN · Healthcare · Healthcare Service Provider · Market cap ₹119 Cr
· Prev close ₹70.10 · Volume 1.73 L · 52W ₹46–152
Company profile: not in our data yet
Net margin 21.8% (FY26)
Median of the other 5: 6.4%
Generated Return on capital is 23.8%, 2nd of 6 listed peers; Invicta Diagnostic is first at 43.6%.
Profit, last 4 quarters vs the 4 before: not in our data yet
0.3× the peers' median
Peers' median 22.8×
Generated At ₹68.12 the share is priced at 6.2× its earnings per share of ₹11.05 for the year to Mar 2026. The P/E at the FY26 year-end was 4.2×; the other 4 listed peers have a median of 22.8×.
Of profit came in as cash, last 5 fiscal years: not in our data yet
100%: all profit arrived as cash
Generated Operating cash was positive in FY26. Total debt was ₹7 cr at the end of FY26, against a net worth of ₹116 cr.
Held by domestic funds: not in our data yet
In 1 month: not in our data yet
Generated The 52-week range runs from ₹46 to ₹152; the 12 Nov close of ₹68.12 sits 21% of the way up. Over 1 year it is down 51.9%, and the close is below its 20-day average of ₹73 and above its 50-day average of ₹65.
Generated from the call summary, restated without adjectives. Open a line for the summary text and the transcript.
4 more takeaways, the guidance changes and the risks named on this call.See Pro
Scored statements from the earnings calls: none yet.
Earnings outlook Generated
In Q4 FY26 (Mar 26), operating margin was 38.1%.
What management guided on the Q4 call is part of Pro.See Pro
Revenue grew 6% YoY to INR88.5cr, PAT up 21% to INR19.3cr
Generated summary